Scientists at Scripps Research have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide.
Described in the journal ACS Infectious Diseases, the new, non-invasive test may provide an inexpensive method of determining in real time whether a person has an infection, which would give public health officials and doctors critical information for tracking outbreaks and treating current infections.
“River blindness affects individuals both in Africa and Latin America, and because many of these endemic regions are difficult to access, what is needed in the field is an inexpensive point-of-care means to monitor the disease,” says Kim Janda, PhD, the Ely R. Callaway Jr. Professor of Chemistry and member of the Skaggs Institute for Chemical Biology at Scripps Research.
River blindness is a filarial disease, like elephantiasis, and occurs when the parasitic worm Onchocerca volvulus takes up residence in the skin. Adult worms pump out babies (microfilaria) at an alarming rate, which are ultimately re-spread by blackfly bites. The microfilariae can migrate to the eye and die, releasing toxins and causing inflammation. People with the disease will slowly go blind without medical intervention.
Janda says onchocerciasis monitoring and evaluation are especially necessary steps for people leading elimination efforts. To know if these efforts are working, doctors need to be able to show when disease transmission has been interrupted. The current gold standard for detecting the parasitic worms is a “skin snip” biopsy. However, snips are generally insensitive indicators of infection, and the sensitivity of the skin snip decreases as the density of microfilaria in the skin decreases. Other tests cannot distinguish between past and current infections.
Currently, onchocerciasis elimination programs rely primarily on mass drug administration of the therapy Ivermectin to suppress and eventually eliminate transmission of Onchocerca volvulus. Yet, without a means to evaluate if an infection is ongoing, it’s hard to assess if prevention efforts are working—and if it’s safe for people to stop taking medication.
The new lateral flow assay took over 10 years to develop, but it is now ready for manufacturing and testing in the field. The key to the assay’s success was in the making of designer antibodies to detect a unique biomarker that only shows up when a human host has metabolized a worm neurotransmitter called tyramine. Humans then secrete this biomarker in urine.
A negative on the “dipstick” test shows a colored line in the test. Got the parasite? The test would show no lines.
Unlike the skin snip biopsy, Janda says this non-invasive test is the first to use a metabolite produced by adult worms. Moreover, the dipstick’s inexpensive design, coupled with smartphone apps, would offer automatic image processing, which ultimately could translate to address critical gaps in the surveillance and treatment of river blindness.
The Latest on: River blindness
via Google News
The Latest on: River blindness
- Notice from Ministry of Healthon October 4, 2020 at 5:00 pm
Uganda has stopped interventions in 2019 among 608,219 people in Nyagak Bondo focus previously treated for river blindness (Onchocerciasis), based on the current World Health Organization (WHO) ...
- Carter Center and Lions Clubs Int’l expand partnership in battle against trachoma, river blindnesson September 26, 2020 at 2:20 pm
During a ceremony held at the Carter Center’s headquarters on May 15, 2014, former U.S. President Jimmy Carter and Lions Clubs International Foundation Chairperson Wayne Madden announced a US $8.8 ...
- Elimination of “river epilepsy” has started in South Sudanon September 25, 2020 at 2:19 am
In November 2013, I visited Mvolo, in South Sudan, in an effort to identify the cause of nodding syndrome, at that time a mysterious form of epilepsy of unknown aetiology. The situation in Mvolo was ...
- In The Quest To Make A Difference, 'A Path Appears'on September 14, 2020 at 12:48 am
I mean, when I first traveled around in Africa, for example, I was really struck by the blindness everywhere. River blindness, trachoma, so many middle-age people who were unproductive and could ...
- Microscope to Diagnose River Blindness Is a Winneron September 9, 2020 at 11:59 pm
A team of innovators from Stanford University has invented the Onchoscope: a low-cost, customizable microscope for the diagnosis of Onchocerciasis, a condition commonly known as “river blindness”. The ...
- Corporate Social Responsibility Press Releaseson September 9, 2020 at 4:59 pm
WHITEHOUSE STATION, N.J. and BOGOTA, Columbia, Nov. 11 /CSRwire/ - Public health officials at the 21st Inter-American Conference on Onchocerciasis in Bogota, Colombia announced that Colombia has ...
- Stanford students design a device to detect early-stage river blindnesson September 9, 2020 at 8:39 am
A team of Stanford undergraduates designed a device that uses blue-light imaging technology to diagnose a parasitic disease called river blindness.
- Malaria breakthrough: Scientists find ‘highly effective’ way to kill parasiteon September 5, 2020 at 5:00 pm
The promise of a new treatment comes after vaccine trials in Burkina Faso proved that Ivermectin, a conventional drug used for parasitic diseases including river blindness and elephantiasis, reduced ...
- Global Health Championson August 17, 2020 at 3:35 am
River blindness, a condition caused by worms that damage the eyes to the point of blindness, affects 12 African nations. With determination and diplomacy, Amazigo has implemented a low-cost ...
- Drugs for worms and river blindness could treat breast canceron July 26, 2020 at 6:26 pm
Cheap drugs to treat parasitic worms and conditions such as river blindness could be used for women with a type of breast cancer that often fails to respond to standard therapies, a new study shows.
via Bing News